Aspirin Significantly Reduces the Severity of the Individual Symptoms of Flushing Associated With Niacin Extended-Release Therapy

被引：0
|
作者：
Lewin, Andrew [1 ]
Kashyap, Moti [2 ]
Jiang, Ping [3 ]
Everhart, Wendy [3 ]
Thakker, Kamlesh [3 ]
机构：
[1] Natl Res Inst, Los Angeles, CA USA
[2] Univ Calif Irvine, Long Beach VA Med Ctr, Irvine, CA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF CARDIOVASCULAR NURSING | 2012年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：373 / 373
页数：1
相关论文
共 50 条
  • [41] Comparative lipid effects of combination therapy with a statin and extended-release niacin versus statin plus ezetimibe versus a statin alone
    McKenney, J. M.
    Jones, P. H.
    Bays, H. E.
    Knopp, R. H.
    Kashyap, M. L.
    Ruoff, G. E.
    Stanek, E. J.
    McGovern, M. E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 174 - 175
  • [42] Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)
    McKenney, James M.
    Jones, Peter H.
    Bays, Harold E.
    Knopp, Robert H.
    Kashyap, Moti L.
    Ruoff, Gary E.
    McGovern, Mark E.
    ATHEROSCLEROSIS, 2007, 192 (02) : 432 - 437
  • [43] Short-term effects of extended-release niacin on endothelial function in HIV-infected patients on stable antiretroviral therapy
    Chow, Dominic C.
    Stein, James H.
    Seto, Todd B.
    Mitchell, Carol
    Sriratanaviriyakul, Narin
    Grandinetti, Andrew
    Gerschenson, Mariana
    Shiramizu, Bruce
    Souza, Scott
    Shikuma, Cecilia
    AIDS, 2010, 24 (07) : 1019 - 1023
  • [44] Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome
    Chow, Dominic C.
    Tasaki, Anne
    Ono, Jill
    Shiramizu, Bruce
    Souza, Scott A.
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 917 - 921
  • [45] Switching the Pharmaceutical Dosage Form of Extended-Release Valproate Is Associated with Therapeutic Modification of Antiepileptic Therapy
    Schuessel, Katrin
    von Klot, Stephanie
    Schulz, Martin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 242 - 242
  • [46] Modeled achievement of optimal lipid values with extended-release niacin/lovastatin versus simvastatin/ezetimibe combination therapy in at-risk patients
    Stanek, EJ
    Quimbo, R
    Cziraky, MJ
    Charland, SL
    VALUE IN HEALTH, 2006, 9 (03) : A120 - A120
  • [47] Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy
    Toth, Peter P.
    Thakker, Kamlesh M.
    Jiang, Ping
    Padley, Robert J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 39 - 44
  • [48] Population-based response estimates for extended-release Niacin/Simvastatin versus other high-potency dyslipidemia therapy in patients with the metabolic syndrome
    Stanek, Eric J.
    Quimbo, Ralph A.
    Cziralky, Mark J.
    Weathermon, Ron A.
    Charland, Scott L.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E114 - E114
  • [49] AN ECONOMIC EVALUATION OF THE ADDITION OF FIXED-DOSE NIACIN EXTENDED-RELEASE AND SIMVASTATIN THERAPY TO THE MANAGED CARE FORMULARY IN TERMS OF OPTIMAL LIPID VALUE ATTAINMENT
    Balu, S.
    Simko, R. J.
    Burge, R. T.
    Cziraky, M. J.
    Quimbo, R. A.
    VALUE IN HEALTH, 2008, 11 (06) : A406 - A406
  • [50] Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the impact of medical subspecialty on patient compliance to treatment (IMPACT) study
    Rubenfire, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (03): : 306 - 311
12345